摘要
个体化治疗是当前非小细胞肺癌的发展趋势，但什么是个体化治疗，为什么要进行个体化治疗，哪些标志物可以用以指导个体化治疗以及如何在非小细胞肺癌中实施个体化治疗是面临的主要问题。文章对上述问题进行了阐述。
Individual therapy is the current trend of treatment in non-small cell lung cancer patient. However, we still face many questions such as what is the individual therapy, why we need individual therapy, which biomarker could be used to guide the individual therapy and how to undergo individual therapy in nonsmall cell lung cancer patient. This article will give a review to answer these questions.
出处
《肿瘤研究与临床》
CAS
2010年第12期793-797,共5页
Cancer Research and Clinic
关键词
癌
非小细胞肺
药物疗法
联合
个体化
Carcinoma, non-small-cell lung
Drug therapy, combination
Individual
